Delisting risk
Humacyte
Commercializing Symvess while expanding its ATEV vessel platform.
$0.6557
After-hours close+0.01 (+0.83%)
At close$0.6503(−6.12%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 44.42%74.63M sharesInsiders 0.65%1.09M sharesOther 54.93%92.28M shares
Shares outstanding 168.00M · Float 138.12M · 82.2% free float
Institutions13F, as of Jun 30, 2026
172 holders · 74.63M shares · 40 new positions · 97 increased · 38 reduced · 35 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 10.11M | 6.02% | +2.95M | Aug 13, 2026 |
| Antipodes Partners Ltd | 10.10M | 6.01% | +4.38M | Aug 6, 2026 |
| Alyeska Investment Group, L.P. | 6.02M | 3.59% | +6.02Mnew | Aug 14, 2026 |
| Davidson Kempner Capital Management LP | 5.00M | 2.98% | +5.00Mnew | Aug 14, 2026 |
| BlackRock, Inc. | 4.84M | 2.88% | −7.48M | Aug 7, 2026 |
| Great Point Partners LLC | 3.75M | 2.23% | 0 | Aug 14, 2026 |
| UBS Group AG | 2.84M | 1.69% | +61.4K | Aug 13, 2026 |
| AQR Capital Management LLC | 2.60M | 1.55% | +672.4K | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 6.30% | 7.54M | Nov 8, 2024 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Dale A. Sander | officer: CFO and Chief Corp. Dev. Off | 307.8K | 0.18% | May 20, 2026 |
| Shamik J. Parikh | officer: Chief Medical Officer | 272.7K | 0.16% | May 20, 2026 |
| Laura E. Niklason | director, officer: President, CEO and Director | 243.9K | 0.15% | Aug 20, 2025 |
| Kathleen Sebelius | director | 148.0K | 0.09% | May 20, 2026 |
| Michael T. Constantino | director | 44.0K | 0.03% | May 20, 2026 |
| Keith Anthony Jones | director | 40.0K | 0.02% | Aug 21, 2026 |
| William John Scheessele | officer: Chief Commercial Officer | 22.0K | 0.01% | Apr 15, 2025 |
| Charles Bruce Green | director | 8.4K | 0.01% | Apr 8, 2025 |
2 ten-percent owners hold 26.50M shares by Form 4, outside the officers-and-directors figure above · 5 people have not refiled in the last 18 months (419.4K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 20, 2026 | Keith Anthony Jonesdirector | Purchase | 10,000 | $0.6930 | 40,000 |
| Aug 17, 2026 | Keith Anthony Jonesdirector | Purchase | 30,000 | $0.5940 | 30,000 |
| May 18, 2026 | Shamik J. Parikhofficer: Chief Medical Officer | Sale | 45,887 | $0.8967 | 272,713 |
| May 18, 2026 | Dale A. Sanderofficer: CFO and Chief Corp. Dev. Off | Sale | 45,887 | $0.8967 | 267,213 |
| May 18, 2026 | Michael T. Constantinodirector | Purchase | 11,000 | $0.8945 | 43,950 |
| May 19, 2026 | Kathleen Sebeliusdirector | Purchase | 56,818 | $0.8800 | 148,025 |
CongressHouse and Senate disclosures
| Member | Type | Amount | Owner | Traded | Disclosed |
|---|---|---|---|---|---|
| Sen. Tommy Tuberville · AL | Purchase | $1,001 – $15,000 | Joint | Mar 21, 2024 | Aug 5, 2026 ↗ |
| Sen. Tommy Tuberville · AL | Purchase | $1,001 – $15,000 | Joint | Mar 21, 2024 | Aug 5, 2026 ↗ |
| Sen. Tommy Tuberville · AL | Purchase | $1,001 – $15,000 | Joint | Mar 21, 2024 | Aug 5, 2026 ↗ |
| Sen. Tommy Tuberville · AL | Purchase | $15,001 – $50,000 | Joint | Mar 21, 2024 | Aug 5, 2026 ↗ |